Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2015-06-15 AGM Information
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
关于召开2014年年度股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement about the convening of the 2014 Annual General Meeting (AGM) of the company 马应龙药业集团股份有限公司. It includes information about the date, voting methods, agenda items to be discussed and voted on, registration procedures, and proxy forms. The document does not contain the actual annual report or financial statements but rather serves as a notice and instructions for shareholders regarding the AGM. The document length is relatively short (3121 characters) and it is clearly an announcement about the meeting rather than the meeting materials or reports themselves. Therefore, it fits the category of AGM Information (AGM-R).
2015-06-15 Chinese
第八届董事会第八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from the company 马应龙药业集团股份有限公司. It details the decision of the board to convene the 2014 annual general meeting (AGM) and mentions the date and method of the AGM. There is no financial data or detailed report content, only a formal announcement of a board decision related to the AGM. This fits the category of Board/Management Information (MANG), as it concerns board meeting resolutions and decisions. The document is short and does not contain financial statements or detailed report content, so it is not an Annual Report or similar. Therefore, the classification is MANG with high confidence.
2015-06-03 Chinese
关于召开2014年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about the convening of the 2014 Annual General Meeting (AGM) of the company 马应龙药业集团股份有限公司. It includes details such as the date and time of the meeting, voting methods, agenda items to be discussed and voted on (including the 2014 annual report and financial statements), and instructions for shareholders on how to attend and vote. The document does not contain the actual annual report or financial statements but rather serves as an announcement and invitation to the AGM. The document length is under 5,000 characters and it primarily provides meeting logistics and voting information. Therefore, it fits the category of AGM Information (AGM-R) rather than the Annual Report (10-K) or Declaration of Voting Results (DVA).
2015-06-03 Chinese
2014年度利润分配说明会预告公告
AGM Information Classification · 95% confidence The document is a notice announcing a profit distribution explanation meeting for the fiscal year 2014, scheduled for June 12, 2015. It references the 2014 Annual Report but does not contain the report itself or detailed financial data. The document is short (1147 characters) and serves to inform investors about the meeting logistics and participation details. It fits the definition of an announcement related to a meeting or event rather than the report itself. Therefore, it is best classified as AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or related investor meetings.
2015-06-03 Chinese
关于发起设立健康产业基金的补充公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about the initiation and supplementary details of establishing a health industry investment fund. It includes information about the investment agreement, company governance, investment decision-making, fund structure, capital contributions, exit strategies, fees, liquidation, dispute resolution, and risk disclosures. There are no financial statements, quarterly or annual results, or audit opinions presented. The document is not a report itself but a regulatory announcement about a financing-related activity (setting up an investment fund). The document length is 3118 characters, which is relatively short and consistent with an announcement rather than a full report. The content focuses on capital structure and investment fund formation, which aligns with a Capital/Financing Update rather than other categories like Annual Report, Interim Report, or Regulatory Filings. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2015-05-19 Chinese
关于发起设立健康产业基金的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company 马应龙药业集团股份有限公司 regarding the initiation and establishment of a health industry investment fund. It details the investment amounts, partners, fund structure, investment scope, decision-making process, and risk analysis. The document is an announcement of a capital investment and fund formation, not a financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial performance data. The content fits best under the category of Capital/Financing Update (CAP), as it relates to the company's fundraising and investment activities through the establishment of a fund.
2015-05-13 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.